Literature DB >> 3207674

Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes.

D K St Clair1, S M Rybak, J F Riordan, B L Vallee.   

Abstract

The translational capacity of a rabbit reticulocyte lysate is rapidly abolished on treatment with angiogenin, an effect that is due to cleavage of rRNA [St. Clair, D. K., Rybak, S. M., Riordan, J. F., & Vallee, B. L. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 8330-8334]. The same time course of inhibition is seen when isolated ribosomes are treated with angiogenin prior to being added to a ribosome-dependent lysate system. In both cases, the onset of inhibition occurs at a rate similar to that seen on addition of puromycin, a known inhibitor of elongation, suggesting that this is the step in the protein synthesis machinery that is inactivated by angiogenin. The action of angiogenin on ribosomes is quite specific: both 28S and 18S rRNAs are cleaved whereas 5.8S and 5S rRNAs are not. Moreover, 28S and 18S rRNAs are affected differently. Prolonged incubation with angiogenin degrades 28S rRNA extensively but only causes limited cleavage of 18S rRNA. Remarkably, it is the effect of angiogenin on 18S rRNA that seems to be responsible for the inhibition of protein synthesis rather than the nucleolytic degradation of 28S rRNA. This has been demonstrated by separating the isolated ribosomes into their 40S and 60S subunits and treating them individually with angiogenin. The pattern of rRNA cleavage is the same with the separated subunits as with intact ribosomes, but translation is abolished only on treatment of the 40S, not the 60S, subunit with angiogenin. These results confirm our previous observations on the effect of angiogenin on the rabbit reticulocyte cell-free translation system and extend the understanding of its mechanism of action on the ribosome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207674     DOI: 10.1021/bi00419a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.

Authors:  Nitika Paudel; Sathish Sadagopan; Sandhya Balasubramanian; Bala Chandran
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.

Authors:  Nitika Paudel; Sathish Sadagopan; Sayan Chakraborty; Grzegorz Sarek; Päivi M Ojala; Bala Chandran
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family.

Authors:  H F Rosenberg; D G Tenen; S J Ackerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  CPA-seq reveals small ncRNAs with methylated nucleosides and diverse termini.

Authors:  Heming Wang; Rong Huang; Ling Li; Junjin Zhu; Zhihong Li; Chao Peng; Xuran Zhuang; Haifan Lin; Shuo Shi; Pengyu Huang
Journal:  Cell Discov       Date:  2021-04-19       Impact factor: 10.849

7.  Deletions at the C-terminus of interferon gamma reduce RNA binding and activation of double-stranded-RNA cleavage by bovine seminal ribonuclease.

Authors:  C H Schein; M Haugg
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

8.  Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons.

Authors:  Nethaji Thiyagarajan; Ross Ferguson; Vasanta Subramanian; K Ravi Acharya
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.